DataMEDS AI Inc MEDS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
DataMEDS AI Signs MOU to Deploy Health Lives Here GLP-1 Patient Management Program with Florida-Based HMO
DataMEDS AI Announces Termination of Second Amended and Restated Letter of Intent
DataMEDS AI Enters Into Agreement for Commercial Supply of Six Peptides Recommended by FDA Advisory Committee
DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network
DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies
DataMeds Regains Compliance With NASDAQ Listing Standards
DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap
DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform
Trading Information
- Previous Close Price
- $1.22
- Day Range
- $1.19–1.20
- 52-Week Range
- $0.82–35.50
- Bid/Ask
- $1.17 / $1.20
- Shares Outstanding
- 5.18M
- Market Cap
- $5.37M
- Volume/Avg
- 1,030 / 6M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.31
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
DataMEDS AI Inc is a healthcare technology and pharmaceutical logistics company. The group simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. Its solutions provide a single, integrated platform for pharmacies, wholesale distribution, and a fulfillment network focused on Independent Pharmacies and Specialty Lite medications.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Growth
- Total Number of Employees
- —
Valuation
Metric | MEDS |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.31 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | MEDS |
|---|---|
Quick Ratio | 0.09 |
Current Ratio | 0.14 |
Interest Coverage | −13.87 |
Quick Ratio
MEDS
Profitability
Metric | MEDS |
|---|---|
Return on Assets (Normalized) | −85.79% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −144.82% |
Return on Assets
MEDS
Medical Distribution Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| McKesson Corp MCK | LOCK|w$C<xPM | LOCK|s>Zq^ | $124B | |||
| Cencora Inc COR | LOCK|<j?!?%^ | LOCK|vYkD | $65B | |||
| Cardinal Health Inc CAH | LOCK|%kK!zk | LOCK|Z#Tm | $62B | |||
| Sigma Healthcare Ltd SIGGF | — | LOCK|%H^t | $23B | |||
| Henry Schein Inc HSIC | LOCK|sLg!!^ | LOCK|bgmq | $9B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR SHPMY | — | LOCK|xg> | $8B | |||
| Sinopharm Group Co Ltd SHTDF | — | LOCK|Z#z | $7B | |||
| Sinopharm Group Co Ltd ADR SHTDY | — | LOCK|#H% | $7B | |||
| Galenica Ltd GALNF | — | LOCK|<K^<w | $6B | |||
| Medipal Holdings Corp MEPDF | — | LOCK|?Sz | $5B |
United States